Top Header Band Top Header Band

NewsRoom

News

Serum Institute of India ships its first set of R21/Matrix-M™ Malaria Vaccine doses to Africa.

20 May, 2024 - Press Release

Serum Institute of India, the world’s largest manufacturer of vaccines by number of doses, marks a significant milestone with the shipment of its first set of R21/Matrix-M™ malaria vaccine to Africa....Read more

ImmunityBio, Serum Institute of India Agree on an Exclusive Arrangement for Global Supply of Bacillus Calmette-Guerin (BCG) Across All Cancer Types.

03 May, 2024 - Press Release

The collaboration will result in BCG manufacture at large scale for use in combination with ANKTIVA®, ImmunityBio’s recently approved treatment for non-muscle invasive bladder cancer. SII will manufacture both standard BCG (“sBCG”) & next-generation recombinant BCG (“iBCG”), creating a long-term solution to chronic BCG supply shortage issues....Read more

Vaccines are a glimmer of hope against malaria, but the battle has only just begun

25 April, 2024

On World Malaria Day, the architects behind the R21/Matrix-M vaccine present their take on the road ahead....Read more

Serum Institute of India and University of Oxford Strike Landmark Licensing Agreement for Meningitis-B Vaccine

16 April, 2024 - Press Release

Serum Institute of India Pvt. Ltd (SIIPL), in collaboration with the University of Oxford, is developing a novel solution for Men-B disease, advancing global accessibility to life-saving vaccines. This partnership will deliver lifesaving protection against Men-B through the production of a chimeric protein-based vaccine....Read more

News

12 April, 2024 - Press Release

In a landmark collaboration announced today, Serum Institute of India (SII), the world’s largest vaccine manufacturer, has joined forces with Univercells, a Belgian biotech innovator, targeting a dramatic increase in accessibility to personalised cancer care. This partnership aims to bring cutting edge treatment options within reach of millions globally...Read more

News

02 October, 2023 - Press Release

The R21/Matrix-M™ malaria vaccine developed by the University of Oxford and the Serum Institute of India, leveraging Novavax’s adjuvant technology, has been recommended for use by the World Health Organization (WHO) after meeting required safety, quality and effectiveness standards.Read more

News

06 July, 2023

Hon'ble UK Minister of State; Science, Technology & Innovation, George Freeman and UK Trade Commissioner for South Asia, Harjinder Kang along with members of the UK Trade Commission visit Serum Institute Of India and meet with SII CEO Adar Poonawalla and Chairman Dr. Cyrus Poonawalla.Read more

News

17 December, 2021 - Press Release

World Health Organization (WHO) has granted Emergency Use Listing (EUL) for NVX-CoV2373, Novavax' recombinant nanoparticle protein-based COVID-19 vaccine 'COVOVAX™' with Matrix-M™ adjuvant, for active immunization of individuals 18 years of age and older.... Read more

News

15 December, 2021

The Poonawalla Vaccines Research Building is to be established at Oxford University following £50m funding commitment from Serum Life Sciences Ltd., a subsidiary of Serum Institute of India Pvt. Ltd.... Read more

News

22 September, 2021

Serum Life Sciences Ltd announces a strategic partnership with Oxford Biomedica, with the objective of building long term capacity in the UK.... Read more

News

16 March, 2021 - BBC HARDtalk

Adar Poonawalla went all-in on a coronavirus vaccine production deal with Astrazeneca, can he make enough to supply the world?.... Read more

News

03 March 2021 - The Economist

By the end of the year, Mr Poonawalla says, it will add 1.5bn covid-19 shots to 1.3bn-1.5bn doses against diseases from measles to tuberculosis that it already produces annually.... Read more

News

28 February, 2021 - BBC News

As pharmaceutical giants ramp up production in the race to vaccinate the world, one firm has shot into the lead.... Read more

News

14 February 2021 - The Guardian

Adar Poonawalla, chief executive of the Serum Institute of India, on vaccines, regulation and what comes next.... Read more

News

12 January, 2021

'An emotional moment for the team at @SerumInstIndia as the first shipments of COVISHIELD finally leave for multiple locations across India',.... Read more

News

23 December, 2020

Serum Institute of India (SIIPL) has partnered with Dynavax Technologies Corporation a biopharmaceutical company focused on developing.... Read more

News

14 December, 2020

Codagenix, Inc., and the Serum Institute of India Pvt. Ltd. (SIIPL) today announced that a Phase 1 clinical trial.... Read more

News

11 November 2020 - Washington Post

Adar Poonawalla is an Indian billionaire whose family-owned firm makes more vaccines a year than any other company on Earth. Ask him about the race for a coronavirus vaccine and he will offer some unvarnished opinions.... Read more

News

29 September, 2020

A further collaboration amongst the Serum Institute of India (SII), the world’s largest vaccine manufacturer by volume, Gavi and the Bill & Melinda Gates Foundation will accelerate.... Read more

News

22 September, 2020

Adar Poonawalla explains the timing, challenges & cost of vaccinating the world against Covid-19.... View Part 1

News

22 September, 2020

Adar Poonawalla explains the timing, challenges & cost of vaccinating the world against Covid-19....View Part 2

News

16 September, 2020

Novavax, Inc. announced an amendment to its existing agreement....Read more

News

08 September, 2020

SpyBiotech has signed an exclusive global licensing agreement with Serum Institute of India for the development of a novel virus-like-particle (VLP) vaccine targeting COVID-19....Read more

News

11 August, 2020

The Serum Institute of India is preparing to crank out a billion doses. And that's just the beginning....Read more

News

7 August, 2020

The Bill & Melinda Gates Foundation said it is backing the world’s largest vaccine maker....Read more

News

7 August, 2020

Geneva, 7 August 2020 – A new landmark collaboration between SII....Read more

News

6 August, 2020

Novavax, Inc. announced a license agreement with Serum Institute of India for the development and commercialization of NVX‑CoV2373, Novavax’ COVID‑19 vaccine candidate, in low- and middle-income countries (LMIC) and India.... Read more

News

01 August 2020 - The New York Times

The world’s largest vaccine producer, the Serum Institute, announced a plan to make hundreds of millions of doses of an unproven inoculation....Read more

News

16 July 2020 - Politico

Meet the Indian drug mogul who’s challenging the West over vaccines

Adar Poonawalla is seizing on the COVID-19 fight to try to break down the policies protecting Big Pharma....Read more

News

04 June, 2020

Poonawalla is betting big on a Covid-19 vaccine, and preparing for the next possible pandemic....Read more